Embla Medical hf
CSE:EMBLA
Embla Medical hf
CSE:EMBLA
Price:
27
DKK
1.89%
Market Cap:
kr11.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
FSA Group Ltd
ASX:FSA
|
AU |
|
Miyakoshi Holdings Inc
TSE:6620
|
JP |
|
Neogen Corp
NASDAQ:NEOG
|
US |
|
Volex PLC
LSE:VLX
|
UK |
|
W
|
Washington Real Estate Investment Trust
F:WRI
|
US |
|
T
|
TG Metals Ltd
ASX:TG6
|
AU |
|
Able Engineering Holdings Ltd
HKEX:1627
|
HK |
|
G
|
GlobalBlock Digital Asset Trading Ltd
XTSX:BLOK
|
CA |
|
S
|
SaltX Technology Holding AB (publ)
STO:SALT B
|
SE |
|
H
|
Hangzhou Yitong New Materials Co Ltd
SZSE:300930
|
CN |
|
C
|
China Tobacco International HK Co Ltd
HKEX:6055
|
HK |
|
AES Brasil Energia SA
BOVESPA:AESB3
|
BR |
|
Radian Group Inc
NYSE:RDN
|
US |
|
Hangzhou Freely Communication Co Ltd
SSE:603602
|
CN |
|
Firstsource Solutions Ltd
NSE:FSL
|
IN |
|
Y
|
Yunnan Tin Co Ltd
SZSE:000960
|
CN |
|
K
|
Karmarts PCL
SET:KAMART
|
TH |
|
H
|
Hallmark Financial Services Inc
OTC:HALL
|
US |
|
Mapletree Pan Asia Commercial Trust
SGX:N2IU
|
SG |
Multiples-Based Value
The Multiples-Based Value of one
EMBLA
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 27 DKK,
Embla Medical hf
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EMBLA Multiples-Based Value
LOCKED
Multiples Across Competitors
EMBLA Competitors Multiples
Embla Medical hf Competitors
Embla Medical hf Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IS |
|
Embla Medical hf
CSE:EMBLA
|
11.5B DKK | 2 | 21.8 | 11.6 | 17.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.6B USD | 4 | 27.4 | 15.7 | 21.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.5B USD | 15.9 | 56.2 | 42.5 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.8B USD | 5 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.2B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.2B USD | 4.6 | 32.1 | 19.1 | 25.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 7.8 | 43.9 | 24.1 | 26.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 10.6 | 42.9 | 30.4 | 33.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD | 2 | 25 | 9.9 | 16.8 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.1B USD | 1.6 | 15.4 | 11.1 | 13.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
